Evidence map›Paper›PMID 37358072›Full record

ArticleeLife2023

Ketamine's rapid antidepressant effects are mediated by Ca

Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, Madison H Wustrau, Isabella G Schmidt, Hadassah Mendez-Vazquez, Latika Khatri, Seonil Kim

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Parvalbumin interneurons under stress: converging mechanisms of vulnerability.The international journal of neuropsychopharmacology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. American ginseng (Journal of ginseng research · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Ketamine Reverses Chronic Stress-Induced Behavioral Changes via the Expression of CaFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anastasiya Zaytseva *Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.
Evelina Bouckova *Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.
McKennon J Wiles *Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.
Madison H Wustrau *Department of Biomedical Sciences, Colorado State University,, Fort Collins, United States.
Isabella G Schmidt *Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.
Hadassah Mendez-VazquezDepartment of Biomedical Sciences, Colorado State University,, Fort Collins, United States.
Latika KhatriDepartment of Cell Biology, New York University Grossman School of Medicine, New York, United States.
Seonil KimMolecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.ORCID 0000-0002-0451-2180
Colorado State University · USNew York University · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Recovery of Synaptic Dysfunction and Memory Loss in Alzheimer's Disease by Selective Co-Activation of Nicotinic Acetylcholine ReceptorsR03AG072102 · NIA · COLORADO STATE UNIVERSITY · PI KIM, SEONIL · 2021 to 2022
$304k
NCATS NIH HHS UL1 TR002535NIA NIH HHS R03 AG072102NIA NIH HHS R03AG072102
6 · The paper itself

Abstract

Ketamine is shown to enhance excitatory synaptic drive in multiple brain areas, which is presumed to underlie its rapid antidepressant effects. Moreover, ketamine's therapeutic actions are likely mediated by enhancing neuronal Ca

Indexed as

KetamineReceptors, AMPAAnimalsAntidepressive AgentsCalcineurinFemaleMaleMiceReceptors, N-Methyl-D-AspartateSynaptic TransmissionAntidepressive AgentsCalcineurinKetamineReceptors, AMPAReceptors, N-Methyl-D-AspartateCa2+-permeable AMPA receptorscalcineurindepressionketaminemouseneuroscience

Identifiers

PMID37358072
PMCPMC10319435
OpenAlexW4382011053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.